What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Psychiatry
The scientist’s investigation covers issues in Panic disorder, Internal medicine, Neuroscience, Amygdala and Anxiety.
The concepts of his Panic disorder study are interwoven with issues in Genetics, Anxiety disorder, Panic and Allele.
The various areas that Jürgen Deckert examines in his Internal medicine study include Antidepressant, Endocrinology, Psychiatry, Depression and Oncology.
In the field of Neuroscience, his study on Prefrontal cortex and Anterior cingulate cortex overlaps with subjects such as Neuropeptide S receptor.
His Amygdala research is multidisciplinary, incorporating elements of Serotonin transporter, 5-HTTLPR, Oxytocin and Serotonergic.
His study looks at the intersection of Anxiety and topics like Gene polymorphism with Adenosine A2A receptor, Adenosine A1 receptor and rs6295.
His most cited work include:
- Excess of High Activity Monoamine Oxidase A Gene Promoter Alleles in Female Patients with Panic Disorder (544 citations)
- Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. (369 citations)
- Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. (260 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Panic disorder, Anxiety, Endocrinology and Clinical psychology.
His Internal medicine research focuses on Depression and how it relates to Randomized controlled trial.
His work carried out in the field of Panic disorder brings together such families of science as Genetics, Anxiety disorder, Panic and Allele.
His biological study spans a wide range of topics, including Developmental psychology and Arousal, Neuroscience.
Jürgen Deckert has researched Endocrinology in several fields, including Receptor and Adenosine A1 receptor.
As part of his studies on Clinical psychology, Jürgen Deckert often connects relevant subjects like Amygdala.
He most often published in these fields:
- Internal medicine (38.24%)
- Panic disorder (32.68%)
- Anxiety (31.70%)
What were the highlights of his more recent work (between 2018-2021)?
- Anxiety (31.70%)
- Internal medicine (38.24%)
- Clinical psychology (16.99%)
In recent papers he was focusing on the following fields of study:
Jürgen Deckert mostly deals with Anxiety, Internal medicine, Clinical psychology, Panic disorder and Major depressive disorder.
He has included themes like Arousal, Pathological, Cognition and Depression in his Anxiety study.
His studies deal with areas such as Quetiapine, Doxepin, Oncology and Cardiology as well as Internal medicine.
Jürgen Deckert interconnects Genome-wide association study, Anxiety disorder, Genetic association, Genotype and Genetic variation in the investigation of issues within Clinical psychology.
His research in Panic disorder is mostly focused on Agoraphobia.
As part of one scientific family, Jürgen Deckert deals mainly with the area of Amygdala, narrowing it down to issues related to the Orbitofrontal cortex, and often Endocrinology.
Between 2018 and 2021, his most popular works were:
- International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci (83 citations)
- A major role for common genetic variation in anxiety disorders (73 citations)
- Genetics of Anxiety Disorders. (17 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Major depressive disorder
His primary areas of study are Anxiety, Internal medicine, Clinical psychology, Panic disorder and Major depressive disorder.
In his research on the topic of Anxiety, rs6265, Generalization and Affect is strongly related with Arousal.
His Internal medicine study combines topics in areas such as Antidepressant, Endocrinology and Oncology.
Jürgen Deckert has included themes like Genome-wide association study, Proband, Anxiety disorder, Genetic association and Genetic variation in his Clinical psychology study.
His Panic disorder research is multidisciplinary, relying on both Serotonin transporter, Cognitive behavioral therapy, Epigenetics and DNA methylation.
His work deals with themes such as Mood, Pharmacogenomic Testing, Psychiatric genetics and Oxcarbazepine, which intersect with Major depressive disorder.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
